Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery


Baselga J 's Articles

[30429379] Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations.

Mondello Patrizia , Brea Elliott J , De Stanchina Elisa , Toska Eneda , Chang Aaron Y , Fennell Myles , Seshan Venkatraman , Garippa Ralph , Scheinberg David A , Baselga José , Wendel Hans-Guido , Younes Anas ,

[30422229] Failure to Accurately Disclose Conflicts of Interest in Article Published in JAMA Otolaryngology-Head & Neck Surgery.

Baselga José ,

[30422165] Failure to Disclose Conflict of Interest in Article Published in JAMA on Detection of Cancer-Related Genes.

Baselga José ,

[30422162] Failure to Accurately Disclose Conflicts of Interest in Articles Published in JAMA Oncology.

Baselga José ,

[30387498] A novel vascular tumor characterized by co-existing HRAS and GNAQ activating mutations.

Castel P , Bagué S , Granell E , Guerrero Vara R , Baselga J , Baselga E ,

[30377213] A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.

Castroviejo-Bermejo Marta , Cruz Cristina , Llop-Guevara Alba , Gutiérrez-Enríquez Sara , Ducy Mandy , Ibrahim Yasir Hussein , Gris-Oliver Albert , Pellegrino Benedetta , Bruna Alejandra , Guzmán Marta , Rodríguez Olga , Grueso Judit , Bonache Sandra , Moles-Fernández Alejandro , Villacampa Guillermo , Viaplana Cristina , Gómez Patricia , Vidal Marc , Peg Vicente , Serres-Créixams Xavier , Dellaire Graham , Simard Jacques , Nuciforo Paolo , Rubio Isabel T , Dientsmann Rodrigo , Barrett J Carl , Caldas Carlos , Baselga José , Saura Cristina , Cortés Javier , Déas Olivier , Jonkers Jos , Masson Jean-Yves , Cairo Stefano , Judde Jean-Gabriel , O'Connor Mark J , Díez Orland , Balmaña Judith , Serra Violeta ,

[30376427] Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.

Latham Alicia , Srinivasan Preethi , Kemel Yelena , Shia Jinru , Bandlamudi Chaitanya , Mandelker Diana , Middha Sumit , Hechtman Jaclyn , Zehir Ahmet , Dubard-Gault Marianne , Tran Christina , Stewart Carolyn , Sheehan Margaret , Penson Alexander , DeLair Deborah , Yaeger Rona , Vijai Joseph , Mukherjee Semanti , Galle Jesse , Dickson Mark A , Janjigian Yelena , O'Reilly Eileen M , Segal Neil , Saltz Leonard B , Reidy-Lagunes Diane , Varghese Anna M , Bajorin Dean , Carlo Maria I , Cadoo Karen , Walsh Michael F , Weiser Martin , Aguilar Julio Garcia , Klimstra David S , Diaz Luis A , Baselga Jose , Zhang Liying , Ladanyi Marc , Hyman David M , Solit David B , Robson Mark E , Taylor Barry S , Offit Kenneth , Berger Michael F , Stadler Zsofia K ,

[30351999] BRAF Inhibition in BRAF-Mutant Gliomas: Results From the VE-BASKET Study.

Kaley Thomas , Touat Mehdi , Subbiah Vivek , Hollebecque Antoine , Rodon Jordi , Lockhart A Craig , Keedy Vicki , Bielle Franck , Hofheinz Ralf-Dieter , Joly Florence , Blay Jean-Yves , Chau Ian , Puzanov Igor , Raje Noopur S , Wolf Jurgen , DeAngelis Lisa M , Makrutzki Martina , Riehl Todd , Pitcher Bethany , Baselga Jose , Hyman David M ,

[30335191] Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.

Lambertini Matteo , Martel Samuel , Campbell Christine , Guillaume Sébastien , Hilbers Florentine S , Schuehly Uwe , Korde Larissa , Azim Hatem A , Di Cosimo Serena , Tenglin Richard C , Huober Jens , Baselga José , Moreno-Aspitia Alvaro , Piccart-Gebhart Martine , Gelber Richard D , de Azambuja Evandro , Ignatiadis Michail ,

[30301790] Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).

Cocco Emiliano , Javier Carmona F , Razavi Pedram , Won Helen H , Cai Yanyan , Rossi Valentina , Chan Carmen , Cownie James , Soong Joanne , Toska Eneda , Shifman Sophie G , Sarotto Ivana , Savas Peter , Wick Michael J , Papadopoulos Kyriakos P , Moriarty Alyssa , Cutler Richard E , Avogadri-Connors Francesca , Lalani Alshad S , Bryce Richard P , Chandarlapaty Sarat , Hyman David M , Solit David B , Boni Valentina , Loi Sherene , Baselga José , Berger Michael F , Montemurro Filippo , Scaltriti Maurizio ,

[30282693] p95HER2-T cell bispecific antibody for breast cancer treatment.

Rius Ruiz Irene , Vicario Rocio , Morancho Beatriz , Morales Cristina Bernadó , Arenas Enrique J , Herter Sylvia , Freimoser-Grundschober Anne , Somandin Jitka , Sam Johannes , Ast Oliver , Barriocanal Águeda Martinez , Luque Antonio , Escorihuela Marta , Varela Ismael , Cuartas Isabel , Nuciforo Paolo , Fasani Roberta , Peg Vicente , Rubio Isabel , Cortés Javier , Serra Violeta , Escriva-de-Romani Santiago , Sperinde Jeff , Chenna Ahmed , Huang Weidong , Winslow John , Albanell Joan , Seoane Joan , Scaltriti Maurizio , Baselga Jose , Tabernero Josep , Umana Pablo , Bacac Marina , Saura Cristina , Klein Christian , Arribas Joaquín ,

[30241001] Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.

Campone Mario , Im Seock-Ah , Iwata Hiroji , Clemons Mark , Ito Yoshinori , Awada Ahmad , Chia Stephen , Jagiełło-Gruszfeld Agnieszka , Pistilli Barbara , Tseng Ling-Ming , Hurvitz Sara , Masuda Norikazu , Cortés Javier , De Laurentiis Michele , Arteaga Carlos L , Jiang Zefei , Jonat Walter , Le Mouhaër Sylvie , Sankaran Banu , Bourdeau Laurence , El-Hashimy Mona , Sellami Dalila , Baselga José ,

[30240327] Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy.

Cruz Cristina , Llop-Guevara Alba , Garber Judy E , Arun Banu K , Pérez Fidalgo José A , Lluch Ana , Telli Melinda L , Fernández Cristian , Kahatt Carmen , Galmarini Carlos M , Soto-Matos Arturo , Alfaro Vicente , Pérez de la Haza Aitor , Domchek Susan M , Antolin Silvia , Vahdat Linda , Tung Nadine M , Lopez Rafael , Arribas Joaquín , Vivancos Ana , Baselga José , Serra Violeta , Balmaña Judith , Isakoff Steven J ,

[30235087] Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial.

Bardia Aditya , Parton Marina , Kümmel Sherko , Estévez Laura G , Huang Chiun-Sheng , Cortés Javier , Ruiz-Borrego Manuel , Telli Melinda L , Martin-Martorell Paloma , López Rafael , Beck J Thaddeus , Ismail-Khan Roohi , Chen Shin-Cheh , Hurvitz Sara A , Mayer Ingrid A , Carreon Daniel , Cameron Scott , Liao Serena , Baselga José , Kim Sung-Bae ,

[30205045] The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.

Razavi Pedram , Chang Matthew T , Xu Guotai , Bandlamudi Chaitanya , Ross Dara S , Vasan Neil , Cai Yanyan , Bielski Craig M , Donoghue Mark T A , Jonsson Philip , Penson Alexander , Shen Ronglai , Pareja Fresia , Kundra Ritika , Middha Sumit , Cheng Michael L , Zehir Ahmet , Kandoth Cyriac , Patel Ruchi , Huberman Kety , Smyth Lillian M , Jhaveri Komal , Modi Shanu , Traina Tiffany A , Dang Chau , Zhang Wen , Weigelt Britta , Li Bob T , Ladanyi Marc , Hyman David M , Schultz Nikolaus , Robson Mark E , Hudis Clifford , Brogi Edi , Viale Agnes , Norton Larry , Dickler Maura N , Berger Michael F , Iacobuzio-Donahue Christine A , Chandarlapaty Sarat , Scaltriti Maurizio , Reis-Filho Jorge S , Solit David B , Taylor Barry S , Baselga José ,

[30158597] Immunohistochemical analysis of estrogen receptor in breast cancer with ESR1 mutations detected by hybrid capture-based next-generation sequencing.

Ross Dara S , Zehir Ahmet , Brogi Edi , Konno Fumiko , Krystel-Whittemore Melissa , Edelweiss Marcia , Berger Michael F , Toy Weiyi , Chandarlapaty Sarat , Razavi Pedram , Baselga José , Wen Hannah Y ,

[30013179] Genome doubling shapes the evolution and prognosis of advanced cancers.

Bielski Craig M , Zehir Ahmet , Penson Alexander V , Donoghue Mark T A , Chatila Walid , Armenia Joshua , Chang Matthew T , Schram Alison M , Jonsson Philip , Bandlamudi Chaitanya , Razavi Pedram , Iyer Gopa , Robson Mark E , Stadler Zsofia K , Schultz Nikolaus , Baselga Jose , Solit David B , Hyman David M , Berger Michael F , Taylor Barry S ,

[30010759] The legacy of Thomas Tursz: building a leading comprehensive cancer center in Europe.

Soria J-C , Baselga J , Piccart M ,

[29989854] Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.

Li Bob T , Shen Ronglai , Buonocore Darren , Olah Zachary T , Ni Ai , Ginsberg Michelle S , Ulaner Gary A , Offin Michael , Feldman Daniel , Hembrough Todd , Cecchi Fabiola , Schwartz Sarit , Pavlakis Nick , Clarke Stephen , Won Helen H , Brzostowski Edyta B , Riely Gregory J , Solit David B , Hyman David M , Drilon Alexander , Rudin Charles M , Berger Michael F , Baselga Jose , Scaltriti Maurizio , Arcila Maria E , Kris Mark G ,

[29902299] Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomized Clinical Trial.

Powles Ryan L , Redmond David , Sotiriou Christos , Loi Sherene , Fumagalli Debora , Nuciforo Paolo , Harbeck Nadia , de Azambuja Evandro , Sarp Severine , Di Cosimo Serena , Huober Jens , Baselga Jose , Piccart-Gebhart Martine , Elemento Olivier , Pusztai Lajos , Hatzis Christos ,

[29882016] Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer.

Rodon Jordi , Pérez-Fidalgo Alejandro , Krop Ian E , Burris Howard , Guerrero-Zotano Angel , Britten Carolyn D , Becerra Carlos , Schellens Jan , Richards Donald A , Schuler Martin , Abu-Khalaf Maysa , Johnson Faye M , Ranson Malcolm , Edenfield Jeff , Silva Antonio P , Hackl Wolfgang , Quadt Cornelia , Demanse David , Duval Vincent , Baselga Jose ,

[29878225] Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

Lambertini Matteo , Campbell Christine , Bines José , Korde Larissa A , Izquierdo Miguel , Fumagalli Debora , Del Mastro Lucia , Ignatiadis Michail , Pritchard Kathleen , Wolff Antonio C , Jackisch Christian , Lang Istvan , Untch Michael , Smith Ian , Boyle Frances , Xu Binghe , Barrios Carlos H , Baselga José , Moreno-Aspitia Alvaro , Piccart Martine , Gelber Richard D , de Azambuja Evandro ,

[29872864] Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors.

Ptashkin Ryan N , Mandelker Diana L , Coombs Catherine C , Bolton Kelly , Yelskaya Zarina , Hyman David M , Solit David B , Baselga José , Arcila Maria E , Ladanyi Marc , Zhang Liying , Levine Ross L , Berger Michael F , Zehir Ahmet ,

[29793946] Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer.

Dickler Maura N , Saura Cristina , Richards Donald A , Krop Ian E , Cervantes Andrés , Bedard Philippe L , Patel Manish R , Pusztai Lajos , Oliveira Mafalda , Cardenas Alison K , Cui Na , Wilson Timothy R , Stout Thomas J , Wei Michael C , Hsu Jerry Y , Baselga José ,

[29733336] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Curigliano G , Burstein H J , Winer E P , Gnant M , Dubsky P , Loibl S , Colleoni M , Regan M M , Piccart-Gebhart M , Senn H-J , Thürlimann B , André F , Baselga J , Bergh J , Bonnefoi H , Brucker S Y , Cardoso F , Carey L , Ciruelos E , Cuzick J , Denkert C , Di Leo A , Ejlertsen B , Francis P , Galimberti V , Garber J , Gulluoglu B , Goodwin P , Harbeck N , Hayes D F , Huang C-S , Huober J , Khaled H , Jassem J , Jiang Z , Karlsson P , Morrow M , Orecchia R , Osborne K C , Pagani O , Partridge A H , Pritchard K , Ro J , Rutgers E J T , Sedlmayer F , Semiglazov V , Shao Z , Smith I , Toi M , Tutt A , Viale G , Watanabe T , Whelan T J , Xu B ,

[29701764] Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial.

Shi W , Jiang T , Nuciforo P , Hatzis C , Holmes E , Harbeck N , Sotiriou C , Peña L , Loi S , Rosa D D , Chia S , Wardley A , Ueno T , Rossari J , Eidtmann H , Armour A , Piccart-Gebhart M , Rimm D L , Baselga J , Pusztai L ,

[29701763] PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

Loibl S , Majewski I , Guarneri V , Nekljudova V , Holmes E , Bria E , Denkert C , Schem C , Sotiriou C , Loi S , Untch M , Conte P , Bernards R , Piccart M , von Minckwitz G , Baselga J ,

[29635390] RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.

Cruz C , Castroviejo-Bermejo M , Gutiérrez-Enríquez S , Llop-Guevara A , Ibrahim Y H , Gris-Oliver A , Bonache S , Morancho B , Bruna A , Rueda O M , Lai Z , Polanska U M , Jones G N , Kristel P , de Bustos L , Guzman M , Rodríguez O , Grueso J , Montalban G , Caratú G , Mancuso F , Fasani R , Jiménez J , Howat W J , Dougherty B , Vivancos A , Nuciforo P , Serres-Créixams X , Rubio I T , Oaknin A , Cadogan E , Barrett J C , Caldas C , Baselga J , Saura C , Cortés J , Arribas J , Jonkers J , Díez O , O'Connor M J , Balmaña J , Serra V ,

[29473716] Magneto-Mechanical Surfaces Design.

Galera Andrés C , San Miguel Verónica , Baselga Juan ,

[29420467] HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman David M , Piha-Paul Sarina A , Won Helen , Rodon Jordi , Saura Cristina , Shapiro Geoffrey I , Juric Dejan , Quinn David I , Moreno Victor , Doger Bernard , Mayer Ingrid A , Boni Valentina , Calvo Emiliano , Loi Sherene , Lockhart Albert C , Erinjeri Joseph P , Scaltriti Maurizio , Ulaner Gary A , Patel Juber , Tang Jiabin , Beer Hannah , Selcuklu S Duygu , Hanrahan Aphrothiti J , Bouvier Nancy , Melcer Myra , Murali Rajmohan , Schram Alison M , Smyth Lillian M , Jhaveri Komal , Li Bob T , Drilon Alexander , Harding James J , Iyer Gopa , Taylor Barry S , Berger Michael F , Cutler Richard E , Xu Feng , Butturini Anna , Eli Lisa D , Mann Grace , Farrell Cynthia , Lalani Alshad S , Bryce Richard P , Arteaga Carlos L , Meric-Bernstam Funda , Baselga José , Solit David B ,

[29401002] Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study.

Juric Dejan , Rodon Jordi , Tabernero Josep , Janku Filip , Burris Howard A , Schellens Jan H M , Middleton Mark R , Berlin Jordan , Schuler Martin , Gil-Martin Marta , Rugo Hope S , Seggewiss-Bernhardt Ruth , Huang Alan , Bootle Douglas , Demanse David , Blumenstein Lars , Coughlin Christina , Quadt Cornelia , Baselga José ,

[29380939] Electromagnetic Shielding Materials in GHz Range.

González Marta , Pozuelo Javier , Baselga Juan ,

[29342137] Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.

Zabala-Letona Amaia , Arruabarrena-Aristorena Amaia , Martín-Martín Natalia , Fernandez-Ruiz Sonia , Sutherland James D , Clasquin Michelle , Tomas-Cortazar Julen , Jimenez Jose , Torres Ines , Quang Phong , Ximenez-Embun Pilar , Bago Ruzica , Ugalde-Olano Aitziber , Loizaga-Iriarte Ana , Lacasa-Viscasillas Isabel , Unda Miguel , Torrano Verónica , Cabrera Diana , van Liempd Sebastiaan M , Cendon Ylenia , Castro Elena , Murray Stuart , Revandkar Ajinkya , Alimonti Andrea , Zhang Yinan , Barnett Amelia , Lein Gina , Pirman David , Cortazar Ana R , Arreal Leire , Prudkin Ludmila , Astobiza Ianire , Valcarcel-Jimenez Lorea , Zuñiga-García Patricia , Fernandez-Dominguez Itziar , Piva Marco , Caro-Maldonado Alfredo , Sánchez-Mosquera Pilar , Castillo-Martín Mireia , Serra Violeta , Beraza Naiara , Gentilella Antonio , Thomas George , Azkargorta Mikel , Elortza Felix , Farràs Rosa , Olmos David , Efeyan Alejo , Anguita Juan , Muñoz Javier , Falcón-Pérez Juan M , Barrio Rosa , Macarulla Teresa , Mato Jose M , Martinez-Chantar Maria L , Cordon-Cardo Carlos , Aransay Ana M , Marks Kevin , Baselga José , Tabernero Josep , Nuciforo Paolo , Manning Brendan D , Marjon Katya , Carracedo Arkaitz ,

[29300831] Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab.

Swain S M , Schneeweiss A , Gianni L , Gao J J , Stein A , Waldron-Lynch M , Heeson S , Beattie M S , Yoo B , Cortes J , Baselga J ,

[29280043] Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06).

Ponde Noam , Bradbury Ian , Lambertini Matteo , Ewer Michael , Campbell Christine , Ameels Helene , Zardavas Dimitrios , Di Cosimo Serena , Baselga José , Huober Jens , Izquierdo Miguel , Fumagalli Debora , Bozovic-Spasojevic Ivana , Maetens Marion , Harbeck Nadia , Pusztai Lajos , Berghorn Michael , Im Young-Hyuck , Borrego Manuel Ruiz , Chen Dar-Ren , Rodeheffer Richard , Piccart Martine , Suter Thomas , de Azambuja Evandro ,

[29247016] Accelerating Discovery of Functional Mutant Alleles in Cancer.

Chang Matthew T , Bhattarai Tripti Shrestha , Schram Alison M , Bielski Craig M , Donoghue Mark T A , Jonsson Philip , Chakravarty Debyani , Phillips Sarah , Kandoth Cyriac , Penson Alexander , Gorelick Alexander , Shamu Tambudzai , Patel Swati , Harris Christopher , Gao JianJiong , Sumer Selcuk Onur , Kundra Ritika , Razavi Pedram , Li Bob T , Reales Dalicia N , Socci Nicholas D , Jayakumaran Gowtham , Zehir Ahmet , Benayed Ryma , Arcila Maria E , Chandarlapaty Sarat , Ladanyi Marc , Schultz Nikolaus , Baselga José , Berger Michael F , Rosen Neal , Solit David B , Hyman David M , Taylor Barry S ,

[29227816] The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO.

Di Cosimo S , Campbell C , Azim H A , Galli G , Bregni G , Curigliano G , Criscitiello C , Izquierdo M , de la Pena L , Fumagalli D , Fein L , Vinholes J , Ng W M J , Colleoni M , Ferro A , Naume B J , Patel A , Huober J , Piccart-Gebhart M J , Baselga J , de Azambuja E ,

[29208392] Concordance between plasma-based and tissue-based next-generation sequencing in LOTUS.

Kim Sung-Bae , Dent Rebecca , Wongchenko Matthew J , Singel Stina M , Baselga José , ,

[29188284] Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.

Diamond Eli L , Subbiah Vivek , Lockhart A Craig , Blay Jean-Yves , Puzanov Igor , Chau Ian , Raje Noopur S , Wolf Jurgen , Erinjeri Joseph P , Torrisi Jean , Lacouture Mario , Elez Elena , Martínez-Valle Ferran , Durham Benjamin , Arcila Maria E , Ulaner Gary , Abdel-Wahab Omar , Pitcher Bethany , Makrutzki Martina , Riehl Todd , Baselga José , Hyman David M ,

[29045519] Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

Dubsky P , Curigliano G , Burstein H J , Winer E P , Gnant M , Loibl S , Colleoni M , Regan M M , Piccart-Gebhart M , Senn H-J , Thürlimann B , , André F , Baselga J , Bergh J , Bonnefoi H , Brucker S Y , Cardoso F , Carey L , Ciruelos E , Cuzick J , Denkert C , Di Leo A , Ejlertsen B , Francis P , Galimberti V , Garber J , Gulluoglu B , Goodwin P , Harbeck N , Hayes D F , Huang C-S , Huober J , Khaled H , Jassem J , Jiang Z , Karlsson P , Morrow M , Orecchia R , Osborne K C , Pagani O , Partridge A H , Pritchard K , Ro J , Rutgers E J T , Sedlmayer F , Semiglazov V , Shao Z , Smith I , Toi M , Tutt A , Viale G , Watanabe T , Whelan T J , Xu B ,

[29042085] Advances in the management of HER2-positive early breast cancer.

Baselga José , Coleman Robert E , Cortés Javier , Janni Wolfgang ,

[28951457] Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition.

Yaeger Rona , Yao Zhan , Hyman David M , Hechtman Jaclyn F , Vakiani Efsevia , Zhao HuiYong , Su Wenjing , Wang Lu , Joelson Andrew , Cercek Andrea , Baselga Jose , de Stanchina Elisa , Saltz Leonard , Berger Michael F , Solit David B , Rosen Neal ,

[28923573] Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).

Loibl Sibylle , de la Pena Lorena , Nekljudova Valentina , Zardavas Dimitrios , Michiels Stefan , Denkert Carsten , Rezai Mahdi , Bermejo Begoña , Untch Michael , Lee Soo Chin , Turri Sabine , Urban Patrick , Kümmel Sherko , Steger Guenther , Gombos Andrea , Lux Michael , Piccart Martine J , Von Minckwitz Gunter , Baselga José , Loi Sherene ,

[28911072] Oncologist use and perception of large panel next-generation tumor sequencing.

Schram A M , Reales D , Galle J , Cambria R , Durany R , Feldman D , Sherman E , Rosenberg J , D'Andrea G , Baxi S , Janjigian Y , Tap W , Dickler M , Baselga J , Taylor B S , Chakravarty D , Gao J , Schultz N , Solit D B , Berger M F , Hyman D M ,

[28899363] A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.

Reynolds Kerry Lynn , Bedard Philippe L , Lee Se-Hoon , Lin Chia-Chi , Tabernero Josep , Alsina Maria , Cohen Ezra , Baselga José , Blumenschein George , Graham Donna M , Garrido-Laguna Ignacio , Juric Dejan , Sharma Sunil , Salgia Ravi , Seroutou Abdelkader , Tian Xianbin , Fernandez Rose , Morozov Alex , Sheng Qing , Ramkumar Thiruvamoor , Zubel Angela , Bang Yung-Jue ,

[28890946] OncoKB: A Precision Oncology Knowledge Base.

Chakravarty Debyani , Gao Jianjiong , Phillips Sarah M , Kundra Ritika , Zhang Hongxin , Wang Jiaojiao , Rudolph Julia E , Yaeger Rona , Soumerai Tara , Nissan Moriah H , Chang Matthew T , Chandarlapaty Sarat , Traina Tiffany A , Paik Paul K , Ho Alan L , Hantash Feras M , Grupe Andrew , Baxi Shrujal S , Callahan Margaret K , Snyder Alexandra , Chi Ping , Danila Daniel , Gounder Mrinal , Harding James J , Hellmann Matthew D , Iyer Gopa , Janjigian Yelena , Kaley Thomas , Levine Douglas A , Lowery Maeve , Omuro Antonio , Postow Michael A , Rathkopf Dana , Shoushtari Alexander N , Shukla Neerav , Voss Martin , Paraiso Ederlinda , Zehir Ahmet , Berger Michael F , Taylor Barry S , Saltz Leonard B , Riely Gregory J , Ladanyi Marc , Hyman David M , Baselga José , Sabbatini Paul , Solit David B , Schultz Nikolaus ,

[28873162] Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.

Mandelker Diana , Zhang Liying , Kemel Yelena , Stadler Zsofia K , Joseph Vijai , Zehir Ahmet , Pradhan Nisha , Arnold Angela , Walsh Michael F , Li Yirong , Balakrishnan Anoop R , Syed Aijazuddin , Prasad Meera , Nafa Khedoudja , Carlo Maria I , Cadoo Karen A , Sheehan Meg , Fleischut Megan H , Salo-Mullen Erin , Trottier Magan , Lipkin Steven M , Lincoln Anne , Mukherjee Semanti , Ravichandran Vignesh , Cambria Roy , Galle Jesse , Abida Wassim , Arcila Marcia E , Benayed Ryma , Shah Ronak , Yu Kenneth , Bajorin Dean F , Coleman Jonathan A , Leach Steven D , Lowery Maeve A , Garcia-Aguilar Julio , Kantoff Philip W , Sawyers Charles L , Dickler Maura N , Saltz Leonard , Motzer Robert J , O'Reilly Eileen M , Scher Howard I , Baselga Jose , Klimstra David S , Solit David B , Hyman David M , Berger Michael F , Ladanyi Marc , Robson Mark E , Offit Kenneth ,

[28838210] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Curigliano G , Burstein H J , P Winer E , Gnant M , Dubsky P , Loibl S , Colleoni M , Regan M M , Piccart-Gebhart M , Senn H-J , Thürlimann B , , André F , Baselga J , Bergh J , Bonnefoi H , Y Brucker S , Cardoso F , Carey L , Ciruelos E , Cuzick J , Denkert C , Di Leo A , Ejlertsen B , Francis P , Galimberti V , Garber J , Gulluoglu B , Goodwin P , Harbeck N , Hayes D F , Huang C-S , Huober J , Hussein K , Jassem J , Jiang Z , Karlsson P , Morrow M , Orecchia R , Osborne K C , Pagani O , Partridge A H , Pritchard K , Ro J , Rutgers E J T , Sedlmayer F , Semiglazov V , Shao Z , Smith I , Toi M , Tutt A , Viale G , Watanabe T , Whelan T J , Xu B ,

[28830796] RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.

Baselga José , Zamagni Claudio , Gómez Patricia , Bermejo Begoña , Nagai Shigenori E , Melichar Bohuslav , Chan Arlene , Mángel Lászlo , Bergh Jonas , Costa Frederico , Gómez Henry L , Gradishar William J , Hudis Clifford A , Rapoport Bernardo L , Roché Henri , Maeda Patricia , Huang Liping , Meinhardt Gerold , Zhang Joshua , Schwartzberg Lee S ,

[28803919] Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.

Coombs Catherine C , Zehir Ahmet , Devlin Sean M , Kishtagari Ashwin , Syed Aijazuddin , Jonsson Philip , Hyman David M , Solit David B , Robson Mark E , Baselga José , Arcila Maria E , Ladanyi Marc , Tallman Martin S , Levine Ross L , Berger Michael F ,

 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur